Search Results

ET_A-receptor blockade impairs vasoconstriction after hemorrhage in xenon-anesthetized dogs treated with an AT₁-receptor antagonist

Authors: Höhne, Claudia; Francis, Roland C.E.; Pickerodt, Philipp; Klein, Adrian; Kaisers, Udo; Boemke, Willehad

Source: Canadian Journal of Physiology and Pharmacology, Volume 86, Number 6, 1 June 2008 , pp. 373-379(7)

Publisher: NRC Research Press

Olmesartan for the treatment of arterial hypertension

Authors: Schindler, Christoph; Ferrario, Carlos M

Source: Future Cardiology, Volume 4, Number 4, July 2008 , pp. 357-372(16)

Publisher: Future Medicine

Reduced levels of cyclic AMP contribute to the enhanced oxidative stress in vascular smooth muscle cells from spontaneously hypertensive rats

Authors: Li, Yuan; Anand-Srivastava, Madhu B.; Saha, Soumya

Source: Canadian Journal of Physiology and Pharmacology, Volume 86, Number 4, 1 April 2008 , pp. 190-198(9)

Publisher: NRC Research Press

Chronic AT1-receptor blockade does not alter cerebral oxygen supply/demand ratio during cardiopulmonary bypass in hypertensive patients

Authors: KOTTENBERG-ASSENMACHER, E.; MASSOUDY, P.; JAKOB, H.; PHILIPP, T.; PETERS, J.

Source: Acta Anaesthesiologica Scandinavica, Volume 52, Number 1, January 2008 , pp. 73-80(8)

Publisher: Blackwell Publishing

Angioödeme durch ACE-Hemmer und AT₁-Rezeptorblocker

Authors: Hellebrand, M.-C.; Kojda, G.; Hoffmann, T.; Bas, M.

Source: Der Hautarzt, Volume 57, Number 9, September 2006 , pp. 808-810(3)

Publisher: Springer

Angiotensin II antagonists – therapeutic benefits spanning the cardiovascular disease continuum from hypertension to heart failure and diabetic nephropathy

Author: Ribeiro, Artur Beltrame

Source: Current Medical Research and Opinion, Volume 22, Number 1, January 2006 , pp. 1-16(16)

Publisher: Informa Healthcare

The Study on COgnition and Prognosis in the Elderly (SCOPE) – Major CV events and stroke in subgroups of patients

Authors: Trenkwalder, Peter; Elmfeldt, Dag; Hofman, Albert; Lithell, Hans; Olofsson, Bertil; Papademetriou, Vasilios; Skoog, Ingmar; Zanchetti, Alberto

Source: Blood Pressure, Volume 14, Number 1, March 2005 , pp. 31-37(7)

Publisher: Informa Healthcare

Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets

Authors: Lau, T.; Carlsson, P.-O.; Leung, P.

Source: Diabetologia, Volume 47, Number 2, February 2004 , pp. 240-248(9)

Publisher: Springer

AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction

Authors: Azadpour, Maziar; Lamas, Gervasio A

Source: Expert Review of Cardiovascular Therapy, Volume 2, Number 6, November 2004 , pp. 891-902(12)

Publisher: Expert Reviews

Telmisartan – killing two birds with one stone

Author: Sheila A Doggrell

Source: Expert Opinion on Pharmacotherapy, Volume 5, Number 11, 1 November 2004 , pp. 2397-2400(4)

Publisher: Informa Healthcare

Candesartan for the treatment of hypertension and heart failure

Author: Jan Östergren

Source: Expert Opinion on Pharmacotherapy, Volume 5, Number 7, 1 July 2004 , pp. 1589-1597(9)

Publisher: Informa Healthcare

Candesartan for the prevention and treatment of stroke – results of the SCOPE and ACCESS trials

Author: Doggrell S.A.

Source: Expert Opinion on Pharmacotherapy, Volume 5, Number 3, 1 March 2004 , pp. 687-690(4)

Publisher: Informa Healthcare

Challenges in improving prognosis and therapy: The Ongoing Telmisartan Alone and in Combination with Ramipril Global End point Trial Programme

Authors: Zimmermann M.; Unger T.

Source: Expert Opinion on Pharmacotherapy, Volume 5, Number 5, 1 May 2004 , pp. 1201-1208(8)

Publisher: Informa Healthcare

Effects of differential blockade of the renin-angiotensin system in postinfarcted rats

Authors: Lacour C.; Roccon A.; Galindo G.; Canals F.; Hogie M.; Segondy D.; Briand D.; Roque C.; Herbert J-M.; Nisato D.

Source: Fundamental & Clinical Pharmacology, Volume 18, Number 3, June 2004 , pp. 299-307(9)

Publisher: Blackwell Publishing

Sympatho-inhibitory actions of irbesartan in pithed spontaneously hypertensive and Wistar-Kyoto rats

Authors: Balt, Jippe C.; Mathy, Marie-Jeanne; Pfaffendorf, Martin; Zwieten, Pieter A.

Source: Fundamental & Clinical Pharmacology, Volume 17, Number 1, February 2003 , pp. 83-91(9)

Publisher: Blackwell Publishing

Inhibiting angiotensin receptors in the brain: possible therapeutic implications

Author: Unger, Thomas

Source: Current Medical Research and Opinion, Volume 19, Number 5, 22 July 2003 , pp. 449-451(3)

Publisher: Informa Healthcare

Circulatory effects of angiotensin II during anaesthesia, evaluated by real-time spectral analysis

Authors: Ullman, J.; Härgestam, R.; Lindahl, S.; Chan, S. H. H.; Eriksson, S.; Rundgren, M.

Source: Acta Anaesthesiologica Scandinavica, Volume 47, Number 5, May 2003 , pp. 532-540(9)

Publisher: Blackwell Publishing

Angiotensin II mediates catecholamine and neuropeptide Y secretion in human adrenal chromaffin cells through the AT₁ receptor

Authors: Cavadas C.; Grand D.; Mosimann F.; Cotrim M.D.; Fontes Ribeiro C.A.; Brunner H.R.; Grouzmann E.

Source: Regulatory Peptides, Volume 111, Number 1, 28 March 2003 , pp. 61-65(5)

Publisher: Elsevier

Down-regulation of bradykinin B₂-receptor mRNA in the heart in pressure-overload cardiac hypertrophy in the rat

Authors: Yayama K.; Matsuoka S.; Nagaoka M.; Shimazu E.; Takano M.; Okamoto H.

Source: Biochemical Pharmacology, Volume 65, Number 6, 15 March 2003 , pp. 1017-1025(9)

Publisher: Elsevier

Non-contribution of renin-angiotensin system to pressor response to N^G-nitro-L-arginine in dogs

Authors: Ishikawa, Tomohisa; Nejishima, Hiromasa; Imamura, Takuya; Nakayama, Koichi

Source: Fundamental & Clinical Pharmacology, Volume 16, Number 1, February 2002 , pp. 15-21(7)

Publisher: Blackwell Publishing